nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—Microtubule Inhibition—Docetaxel—prostate cancer	0.278	1	CiPCiCtD
Cabazitaxel—Docetaxel—prostate cancer	0.265	1	CrCtD
Cabazitaxel—Paclitaxel—Docetaxel—prostate cancer	0.149	1	CrCrCtD
Cabazitaxel—CYP3A5—prostate cancer	0.0449	0.698	CbGaD
Cabazitaxel—CYP3A4—prostate cancer	0.0194	0.302	CbGaD
Cabazitaxel—TUBB8—Docetaxel—prostate cancer	0.00862	0.0549	CbGbCtD
Cabazitaxel—TUBB2B—Docetaxel—prostate cancer	0.00862	0.0549	CbGbCtD
Cabazitaxel—TUBB6—Docetaxel—prostate cancer	0.00862	0.0549	CbGbCtD
Cabazitaxel—TUBB4A—Docetaxel—prostate cancer	0.00862	0.0549	CbGbCtD
Cabazitaxel—TUBB3—Docetaxel—prostate cancer	0.00862	0.0549	CbGbCtD
Cabazitaxel—TUBB2A—Docetaxel—prostate cancer	0.00862	0.0549	CbGbCtD
Cabazitaxel—TUBB4B—Docetaxel—prostate cancer	0.00721	0.0459	CbGbCtD
Cabazitaxel—TUBB1—Docetaxel—prostate cancer	0.00721	0.0459	CbGbCtD
Cabazitaxel—TUBB—Docetaxel—prostate cancer	0.00721	0.0459	CbGbCtD
Cabazitaxel—SLCO1B3—Conjugated Estrogens—prostate cancer	0.00586	0.0374	CbGbCtD
Cabazitaxel—SLCO1B1—Estrone—prostate cancer	0.00522	0.0333	CbGbCtD
Cabazitaxel—SLCO1B3—Estradiol—prostate cancer	0.00515	0.0328	CbGbCtD
Cabazitaxel—ABCG2—Estrone—prostate cancer	0.00415	0.0264	CbGbCtD
Cabazitaxel—CYP2C8—Nilutamide—prostate cancer	0.00369	0.0235	CbGbCtD
Cabazitaxel—SLCO1B1—Conjugated Estrogens—prostate cancer	0.00342	0.0218	CbGbCtD
Cabazitaxel—CYP3A5—Flutamide—prostate cancer	0.00318	0.0202	CbGbCtD
Cabazitaxel—SLCO1B3—Docetaxel—prostate cancer	0.00308	0.0196	CbGbCtD
Cabazitaxel—CYP2C8—Abiraterone—prostate cancer	0.00306	0.0195	CbGbCtD
Cabazitaxel—SLCO1B1—Estradiol—prostate cancer	0.003	0.0191	CbGbCtD
Cabazitaxel—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00285	0.0181	CbGbCtD
Cabazitaxel—ABCG2—Conjugated Estrogens—prostate cancer	0.00271	0.0173	CbGbCtD
Cabazitaxel—ABCG2—Mitoxantrone—prostate cancer	0.00247	0.0157	CbGbCtD
Cabazitaxel—ABCG2—Estradiol—prostate cancer	0.00238	0.0152	CbGbCtD
Cabazitaxel—ABCB1—Estramustine—prostate cancer	0.00232	0.0148	CbGbCtD
Cabazitaxel—CYP3A5—Estrone—prostate cancer	0.0023	0.0146	CbGbCtD
Cabazitaxel—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00197	0.0125	CbGbCtD
Cabazitaxel—ABCG2—Etoposide—prostate cancer	0.00156	0.00991	CbGbCtD
Cabazitaxel—CYP3A4—Bicalutamide—prostate cancer	0.0015	0.00953	CbGbCtD
Cabazitaxel—ABCB1—Estrone—prostate cancer	0.0015	0.00953	CbGbCtD
Cabazitaxel—ABCG2—Docetaxel—prostate cancer	0.00142	0.00907	CbGbCtD
Cabazitaxel—CYP3A4—Estramustine—prostate cancer	0.00139	0.00886	CbGbCtD
Cabazitaxel—ABCB1—Ethinyl Estradiol—prostate cancer	0.00133	0.00849	CbGbCtD
Cabazitaxel—CYP3A5—Estradiol—prostate cancer	0.00132	0.00841	CbGbCtD
Cabazitaxel—CYP2C8—Estradiol—prostate cancer	0.00127	0.00808	CbGbCtD
Cabazitaxel—CYP3A4—Abiraterone—prostate cancer	0.00124	0.00789	CbGbCtD
Cabazitaxel—CYP3A4—Flutamide—prostate cancer	0.00124	0.00789	CbGbCtD
Cabazitaxel—ABCG2—Doxorubicin—prostate cancer	0.00106	0.00676	CbGbCtD
Cabazitaxel—ABCB1—Conjugated Estrogens—prostate cancer	0.000978	0.00623	CbGbCtD
Cabazitaxel—CYP3A4—Estrone—prostate cancer	0.000896	0.00571	CbGbCtD
Cabazitaxel—ABCB1—Mitoxantrone—prostate cancer	0.000889	0.00567	CbGbCtD
Cabazitaxel—CYP3A5—Etoposide—prostate cancer	0.000862	0.00549	CbGbCtD
Cabazitaxel—ABCB1—Estradiol—prostate cancer	0.000859	0.00547	CbGbCtD
Cabazitaxel—CYP2C8—Etoposide—prostate cancer	0.000828	0.00528	CbGbCtD
Cabazitaxel—CYP3A4—Ethinyl Estradiol—prostate cancer	0.000799	0.00509	CbGbCtD
Cabazitaxel—CYP3A5—Docetaxel—prostate cancer	0.000788	0.00502	CbGbCtD
Cabazitaxel—ABCB1—Prednisone—prostate cancer	0.000739	0.00471	CbGbCtD
Cabazitaxel—CYP3A4—Conjugated Estrogens—prostate cancer	0.000586	0.00373	CbGbCtD
Cabazitaxel—ABCB1—Etoposide—prostate cancer	0.000561	0.00357	CbGbCtD
Cabazitaxel—CYP3A4—Mitoxantrone—prostate cancer	0.000533	0.00339	CbGbCtD
Cabazitaxel—CYP3A4—Estradiol—prostate cancer	0.000515	0.00328	CbGbCtD
Cabazitaxel—ABCB1—Docetaxel—prostate cancer	0.000513	0.00327	CbGbCtD
Cabazitaxel—CYP3A4—Prednisone—prostate cancer	0.000442	0.00282	CbGbCtD
Cabazitaxel—TUBA4A—prostate gland—prostate cancer	0.000435	0.0337	CbGeAlD
Cabazitaxel—ABCB1—Doxorubicin—prostate cancer	0.000382	0.00244	CbGbCtD
Cabazitaxel—TUBB8—testis—prostate cancer	0.00037	0.0287	CbGeAlD
Cabazitaxel—TUBA4A—seminal vesicle—prostate cancer	0.000368	0.0285	CbGeAlD
Cabazitaxel—TUBB4A—prostate gland—prostate cancer	0.000349	0.027	CbGeAlD
Cabazitaxel—TUBB2B—prostate gland—prostate cancer	0.000337	0.0261	CbGeAlD
Cabazitaxel—CYP3A4—Etoposide—prostate cancer	0.000336	0.00214	CbGbCtD
Cabazitaxel—TUBA4A—epithelium—prostate cancer	0.00032	0.0248	CbGeAlD
Cabazitaxel—TUBB—prostate gland—prostate cancer	0.000319	0.0247	CbGeAlD
Cabazitaxel—TUBB2A—prostate gland—prostate cancer	0.000317	0.0246	CbGeAlD
Cabazitaxel—TUBB6—prostate gland—prostate cancer	0.000313	0.0242	CbGeAlD
Cabazitaxel—CYP3A4—urine—prostate cancer	0.000311	0.0241	CbGeAlD
Cabazitaxel—CYP3A4—Docetaxel—prostate cancer	0.000307	0.00196	CbGbCtD
Cabazitaxel—TUBA4A—renal system—prostate cancer	0.000297	0.023	CbGeAlD
Cabazitaxel—TUBA4A—urethra—prostate cancer	0.000291	0.0226	CbGeAlD
Cabazitaxel—TUBB1—bone marrow—prostate cancer	0.000289	0.0224	CbGeAlD
Cabazitaxel—TUBB2B—seminal vesicle—prostate cancer	0.000285	0.0221	CbGeAlD
Cabazitaxel—TUBB4B—prostate gland—prostate cancer	0.000272	0.0211	CbGeAlD
Cabazitaxel—TUBB—seminal vesicle—prostate cancer	0.00027	0.0209	CbGeAlD
Cabazitaxel—TUBB2A—seminal vesicle—prostate cancer	0.000268	0.0208	CbGeAlD
Cabazitaxel—TUBB6—seminal vesicle—prostate cancer	0.000265	0.0205	CbGeAlD
Cabazitaxel—TUBB3—testis—prostate cancer	0.000253	0.0196	CbGeAlD
Cabazitaxel—TUBB1—testis—prostate cancer	0.000247	0.0191	CbGeAlD
Cabazitaxel—TUBB4A—renal system—prostate cancer	0.000238	0.0184	CbGeAlD
Cabazitaxel—TUBB4B—seminal vesicle—prostate cancer	0.00023	0.0178	CbGeAlD
Cabazitaxel—TUBB6—epithelium—prostate cancer	0.00023	0.0178	CbGeAlD
Cabazitaxel—TUBB2B—renal system—prostate cancer	0.00023	0.0178	CbGeAlD
Cabazitaxel—CYP3A4—Doxorubicin—prostate cancer	0.000229	0.00146	CbGbCtD
Cabazitaxel—TUBB2B—urethra—prostate cancer	0.000226	0.0175	CbGeAlD
Cabazitaxel—TUBA4A—bone marrow—prostate cancer	0.000224	0.0174	CbGeAlD
Cabazitaxel—TUBB—urethra—prostate cancer	0.000214	0.0165	CbGeAlD
Cabazitaxel—TUBB6—renal system—prostate cancer	0.000213	0.0165	CbGeAlD
Cabazitaxel—TUBB2A—urethra—prostate cancer	0.000212	0.0165	CbGeAlD
Cabazitaxel—TUBB6—urethra—prostate cancer	0.00021	0.0162	CbGeAlD
Cabazitaxel—SLCO1B1—renal system—prostate cancer	0.000198	0.0153	CbGeAlD
Cabazitaxel—TUBA4A—testis—prostate cancer	0.000192	0.0149	CbGeAlD
Cabazitaxel—TUBB4B—renal system—prostate cancer	0.000185	0.0144	CbGeAlD
Cabazitaxel—Paclitaxel—BCL2—prostate cancer	0.000183	0.163	CrCbGaD
Cabazitaxel—Docetaxel—BCL2—prostate cancer	0.000183	0.163	CrCbGaD
Cabazitaxel—TUBB4B—urethra—prostate cancer	0.000182	0.0141	CbGeAlD
Cabazitaxel—TUBB6—Fulvestrant—Estradiol—prostate cancer	0.000167	0.395	CbGdCrCtD
Cabazitaxel—TUBB—bone marrow—prostate cancer	0.000164	0.0127	CbGeAlD
Cabazitaxel—TUBB2A—bone marrow—prostate cancer	0.000164	0.0127	CbGeAlD
Cabazitaxel—TUBB6—bone marrow—prostate cancer	0.000161	0.0125	CbGeAlD
Cabazitaxel—ABCG2—prostate gland—prostate cancer	0.00016	0.0124	CbGeAlD
Cabazitaxel—TUBB4A—testis—prostate cancer	0.000154	0.0119	CbGeAlD
Cabazitaxel—CYP3A5—prostate gland—prostate cancer	0.000149	0.0115	CbGeAlD
Cabazitaxel—TUBB2B—testis—prostate cancer	0.000149	0.0115	CbGeAlD
Cabazitaxel—TUBB6—Levorphanol—Estrone—prostate cancer	0.000146	0.344	CbGdCrCtD
Cabazitaxel—TUBB—testis—prostate cancer	0.000141	0.0109	CbGeAlD
Cabazitaxel—TUBB4B—bone marrow—prostate cancer	0.00014	0.0109	CbGeAlD
Cabazitaxel—TUBB2A—testis—prostate cancer	0.00014	0.0108	CbGeAlD
Cabazitaxel—TUBA4A—lymph node—prostate cancer	0.000139	0.0108	CbGeAlD
Cabazitaxel—TUBB6—testis—prostate cancer	0.000138	0.0107	CbGeAlD
Cabazitaxel—ABCG2—seminal vesicle—prostate cancer	0.000136	0.0105	CbGeAlD
Cabazitaxel—Docetaxel—CYP1B1—prostate cancer	0.000127	0.113	CrCbGaD
Cabazitaxel—Paclitaxel—CYP1B1—prostate cancer	0.000127	0.113	CrCbGaD
Cabazitaxel—Docetaxel—EGFR—prostate cancer	0.00012	0.107	CrCbGaD
Cabazitaxel—TUBB4B—testis—prostate cancer	0.00012	0.00928	CbGeAlD
Cabazitaxel—CYP2C8—renal system—prostate cancer	0.000112	0.00871	CbGeAlD
Cabazitaxel—TUBB4A—lymph node—prostate cancer	0.000111	0.00863	CbGeAlD
Cabazitaxel—TUBB6—Levorphanol—Estradiol—prostate cancer	0.00011	0.261	CbGdCrCtD
Cabazitaxel—TUBB2B—lymph node—prostate cancer	0.000108	0.00834	CbGeAlD
Cabazitaxel—ABCG2—urethra—prostate cancer	0.000107	0.00832	CbGeAlD
Cabazitaxel—TUBB—lymph node—prostate cancer	0.000102	0.00789	CbGeAlD
Cabazitaxel—CYP3A5—renal system—prostate cancer	0.000102	0.00786	CbGeAlD
Cabazitaxel—TUBB2A—lymph node—prostate cancer	0.000101	0.00785	CbGeAlD
Cabazitaxel—Paclitaxel—CYP3A5—prostate cancer	0.000101	0.09	CrCbGaD
Cabazitaxel—Docetaxel—CYP3A5—prostate cancer	0.000101	0.09	CrCbGaD
Cabazitaxel—TUBB6—lymph node—prostate cancer	9.99e-05	0.00774	CbGeAlD
Cabazitaxel—Paclitaxel—CYP19A1—prostate cancer	9.33e-05	0.083	CrCbGaD
Cabazitaxel—TUBB4B—lymph node—prostate cancer	8.69e-05	0.00673	CbGeAlD
Cabazitaxel—ABCG2—bone marrow—prostate cancer	8.27e-05	0.00641	CbGeAlD
Cabazitaxel—ABCB1—prostate gland—prostate cancer	7.91e-05	0.00613	CbGeAlD
Cabazitaxel—CYP3A4—renal system—prostate cancer	7.62e-05	0.0059	CbGeAlD
Cabazitaxel—CYP2C8—testis—prostate cancer	7.27e-05	0.00563	CbGeAlD
Cabazitaxel—ABCG2—testis—prostate cancer	7.07e-05	0.00548	CbGeAlD
Cabazitaxel—ABCB1—seminal vesicle—prostate cancer	6.69e-05	0.00518	CbGeAlD
Cabazitaxel—ABCB1—epithelium—prostate cancer	5.81e-05	0.0045	CbGeAlD
Cabazitaxel—ABCB1—renal system—prostate cancer	5.39e-05	0.00418	CbGeAlD
Cabazitaxel—ABCB1—urethra—prostate cancer	5.3e-05	0.0041	CbGeAlD
Cabazitaxel—ABCG2—lymph node—prostate cancer	5.12e-05	0.00397	CbGeAlD
Cabazitaxel—Paclitaxel—CYP3A4—prostate cancer	4.38e-05	0.039	CrCbGaD
Cabazitaxel—Docetaxel—CYP3A4—prostate cancer	4.38e-05	0.039	CrCbGaD
Cabazitaxel—ABCB1—bone marrow—prostate cancer	4.08e-05	0.00316	CbGeAlD
Cabazitaxel—ABCB1—testis—prostate cancer	3.49e-05	0.0027	CbGeAlD
Cabazitaxel—ABCB1—lymph node—prostate cancer	2.53e-05	0.00196	CbGeAlD
Cabazitaxel—Anxiety—Capecitabine—prostate cancer	1.21e-05	0.000283	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	1.2e-05	0.000282	CcSEcCtD
Cabazitaxel—Oedema—Docetaxel—prostate cancer	1.2e-05	0.000281	CcSEcCtD
Cabazitaxel—Discomfort—Capecitabine—prostate cancer	1.2e-05	0.00028	CcSEcCtD
Cabazitaxel—Infection—Docetaxel—prostate cancer	1.19e-05	0.000279	CcSEcCtD
Cabazitaxel—Weight decreased—Doxorubicin—prostate cancer	1.19e-05	0.000279	CcSEcCtD
Cabazitaxel—Feeling abnormal—Etoposide—prostate cancer	1.19e-05	0.000279	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Doxorubicin—prostate cancer	1.19e-05	0.000278	CcSEcCtD
Cabazitaxel—Diarrhoea—Mitoxantrone—prostate cancer	1.19e-05	0.000278	CcSEcCtD
Cabazitaxel—Dry mouth—Capecitabine—prostate cancer	1.19e-05	0.000278	CcSEcCtD
Cabazitaxel—Vomiting—Estradiol—prostate cancer	1.19e-05	0.000277	CcSEcCtD
Cabazitaxel—Pneumonia—Doxorubicin—prostate cancer	1.18e-05	0.000277	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Etoposide—prostate cancer	1.18e-05	0.000277	CcSEcCtD
Cabazitaxel—Nervous system disorder—Docetaxel—prostate cancer	1.18e-05	0.000276	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Prednisone—prostate cancer	1.18e-05	0.000276	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Docetaxel—prostate cancer	1.18e-05	0.000275	CcSEcCtD
Cabazitaxel—Infestation NOS—Doxorubicin—prostate cancer	1.18e-05	0.000275	CcSEcCtD
Cabazitaxel—Infestation—Doxorubicin—prostate cancer	1.18e-05	0.000275	CcSEcCtD
Cabazitaxel—Anaemia—Prednisone—prostate cancer	1.17e-05	0.000274	CcSEcCtD
Cabazitaxel—Confusional state—Capecitabine—prostate cancer	1.17e-05	0.000274	CcSEcCtD
Cabazitaxel—Tachycardia—Docetaxel—prostate cancer	1.17e-05	0.000274	CcSEcCtD
Cabazitaxel—Headache—Estradiol—prostate cancer	1.17e-05	0.000273	CcSEcCtD
Cabazitaxel—Skin disorder—Docetaxel—prostate cancer	1.17e-05	0.000273	CcSEcCtD
Cabazitaxel—Oedema—Capecitabine—prostate cancer	1.16e-05	0.000272	CcSEcCtD
Cabazitaxel—Renal failure—Doxorubicin—prostate cancer	1.16e-05	0.00027	CcSEcCtD
Cabazitaxel—Infection—Capecitabine—prostate cancer	1.16e-05	0.00027	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Doxorubicin—prostate cancer	1.15e-05	0.00027	CcSEcCtD
Cabazitaxel—Anorexia—Docetaxel—prostate cancer	1.14e-05	0.000268	CcSEcCtD
Cabazitaxel—Malaise—Prednisone—prostate cancer	1.14e-05	0.000268	CcSEcCtD
Cabazitaxel—Abdominal pain—Etoposide—prostate cancer	1.14e-05	0.000267	CcSEcCtD
Cabazitaxel—Body temperature increased—Etoposide—prostate cancer	1.14e-05	0.000267	CcSEcCtD
Cabazitaxel—Conjunctivitis—Doxorubicin—prostate cancer	1.14e-05	0.000267	CcSEcCtD
Cabazitaxel—Urinary tract infection—Doxorubicin—prostate cancer	1.14e-05	0.000267	CcSEcCtD
Cabazitaxel—Nervous system disorder—Capecitabine—prostate cancer	1.14e-05	0.000267	CcSEcCtD
Cabazitaxel—Vertigo—Prednisone—prostate cancer	1.14e-05	0.000267	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Capecitabine—prostate cancer	1.14e-05	0.000266	CcSEcCtD
Cabazitaxel—Tachycardia—Capecitabine—prostate cancer	1.13e-05	0.000266	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Epirubicin—prostate cancer	1.13e-05	0.000265	CcSEcCtD
Cabazitaxel—Skin disorder—Capecitabine—prostate cancer	1.13e-05	0.000264	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Epirubicin—prostate cancer	1.13e-05	0.000263	CcSEcCtD
Cabazitaxel—Oedema peripheral—Epirubicin—prostate cancer	1.12e-05	0.000263	CcSEcCtD
Cabazitaxel—Hypotension—Docetaxel—prostate cancer	1.12e-05	0.000263	CcSEcCtD
Cabazitaxel—Haematuria—Doxorubicin—prostate cancer	1.12e-05	0.000262	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Epirubicin—prostate cancer	1.12e-05	0.000262	CcSEcCtD
Cabazitaxel—Urethral disorder—Epirubicin—prostate cancer	1.12e-05	0.000262	CcSEcCtD
Cabazitaxel—Anorexia—Capecitabine—prostate cancer	1.11e-05	0.000259	CcSEcCtD
Cabazitaxel—Nausea—Estradiol—prostate cancer	1.11e-05	0.000259	CcSEcCtD
Cabazitaxel—Vomiting—Mitoxantrone—prostate cancer	1.1e-05	0.000258	CcSEcCtD
Cabazitaxel—Hypertension—Prednisone—prostate cancer	1.1e-05	0.000256	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Docetaxel—prostate cancer	1.09e-05	0.000256	CcSEcCtD
Cabazitaxel—Headache—Mitoxantrone—prostate cancer	1.09e-05	0.000255	CcSEcCtD
Cabazitaxel—Hypotension—Capecitabine—prostate cancer	1.09e-05	0.000254	CcSEcCtD
Cabazitaxel—Arthralgia—Prednisone—prostate cancer	1.08e-05	0.000253	CcSEcCtD
Cabazitaxel—Myalgia—Prednisone—prostate cancer	1.08e-05	0.000253	CcSEcCtD
Cabazitaxel—Paraesthesia—Docetaxel—prostate cancer	1.08e-05	0.000252	CcSEcCtD
Cabazitaxel—Anxiety—Prednisone—prostate cancer	1.08e-05	0.000252	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	1.07e-05	0.000251	CcSEcCtD
Cabazitaxel—Dyspnoea—Docetaxel—prostate cancer	1.07e-05	0.000251	CcSEcCtD
Cabazitaxel—Discomfort—Prednisone—prostate cancer	1.07e-05	0.00025	CcSEcCtD
Cabazitaxel—Eye disorder—Epirubicin—prostate cancer	1.07e-05	0.000249	CcSEcCtD
Cabazitaxel—Hypersensitivity—Etoposide—prostate cancer	1.06e-05	0.000249	CcSEcCtD
Cabazitaxel—Tinnitus—Epirubicin—prostate cancer	1.06e-05	0.000249	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Capecitabine—prostate cancer	1.06e-05	0.000248	CcSEcCtD
Cabazitaxel—Cardiac disorder—Epirubicin—prostate cancer	1.06e-05	0.000248	CcSEcCtD
Cabazitaxel—Flushing—Epirubicin—prostate cancer	1.06e-05	0.000248	CcSEcCtD
Cabazitaxel—Dyspepsia—Docetaxel—prostate cancer	1.06e-05	0.000247	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Doxorubicin—prostate cancer	1.05e-05	0.000246	CcSEcCtD
Cabazitaxel—Paraesthesia—Capecitabine—prostate cancer	1.04e-05	0.000244	CcSEcCtD
Cabazitaxel—Decreased appetite—Docetaxel—prostate cancer	1.04e-05	0.000244	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Doxorubicin—prostate cancer	1.04e-05	0.000244	CcSEcCtD
Cabazitaxel—Oedema peripheral—Doxorubicin—prostate cancer	1.04e-05	0.000243	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Docetaxel—prostate cancer	1.04e-05	0.000243	CcSEcCtD
Cabazitaxel—Asthenia—Etoposide—prostate cancer	1.04e-05	0.000243	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Doxorubicin—prostate cancer	1.04e-05	0.000243	CcSEcCtD
Cabazitaxel—Dyspnoea—Capecitabine—prostate cancer	1.04e-05	0.000243	CcSEcCtD
Cabazitaxel—Oedema—Prednisone—prostate cancer	1.04e-05	0.000242	CcSEcCtD
Cabazitaxel—Fatigue—Docetaxel—prostate cancer	1.04e-05	0.000242	CcSEcCtD
Cabazitaxel—Angiopathy—Epirubicin—prostate cancer	1.03e-05	0.000242	CcSEcCtD
Cabazitaxel—Urethral disorder—Doxorubicin—prostate cancer	1.03e-05	0.000242	CcSEcCtD
Cabazitaxel—Nausea—Mitoxantrone—prostate cancer	1.03e-05	0.000241	CcSEcCtD
Cabazitaxel—Immune system disorder—Epirubicin—prostate cancer	1.03e-05	0.000241	CcSEcCtD
Cabazitaxel—Infection—Prednisone—prostate cancer	1.03e-05	0.000241	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Epirubicin—prostate cancer	1.03e-05	0.00024	CcSEcCtD
Cabazitaxel—Pain—Docetaxel—prostate cancer	1.03e-05	0.00024	CcSEcCtD
Cabazitaxel—Constipation—Docetaxel—prostate cancer	1.03e-05	0.00024	CcSEcCtD
Cabazitaxel—Dyspepsia—Capecitabine—prostate cancer	1.02e-05	0.00024	CcSEcCtD
Cabazitaxel—Chills—Epirubicin—prostate cancer	1.02e-05	0.000239	CcSEcCtD
Cabazitaxel—Arrhythmia—Epirubicin—prostate cancer	1.02e-05	0.000238	CcSEcCtD
Cabazitaxel—Nervous system disorder—Prednisone—prostate cancer	1.02e-05	0.000238	CcSEcCtD
Cabazitaxel—Tachycardia—Prednisone—prostate cancer	1.01e-05	0.000237	CcSEcCtD
Cabazitaxel—Decreased appetite—Capecitabine—prostate cancer	1.01e-05	0.000237	CcSEcCtD
Cabazitaxel—Alopecia—Epirubicin—prostate cancer	1.01e-05	0.000236	CcSEcCtD
Cabazitaxel—Skin disorder—Prednisone—prostate cancer	1.01e-05	0.000235	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Capecitabine—prostate cancer	1e-05	0.000235	CcSEcCtD
Cabazitaxel—Fatigue—Capecitabine—prostate cancer	1e-05	0.000235	CcSEcCtD
Cabazitaxel—Mental disorder—Epirubicin—prostate cancer	9.99e-06	0.000234	CcSEcCtD
Cabazitaxel—Pain—Capecitabine—prostate cancer	9.94e-06	0.000233	CcSEcCtD
Cabazitaxel—Constipation—Capecitabine—prostate cancer	9.94e-06	0.000233	CcSEcCtD
Cabazitaxel—Erythema—Epirubicin—prostate cancer	9.93e-06	0.000232	CcSEcCtD
Cabazitaxel—Malnutrition—Epirubicin—prostate cancer	9.93e-06	0.000232	CcSEcCtD
Cabazitaxel—Feeling abnormal—Docetaxel—prostate cancer	9.9e-06	0.000232	CcSEcCtD
Cabazitaxel—Diarrhoea—Etoposide—prostate cancer	9.89e-06	0.000231	CcSEcCtD
Cabazitaxel—Anorexia—Prednisone—prostate cancer	9.87e-06	0.000231	CcSEcCtD
Cabazitaxel—Eye disorder—Doxorubicin—prostate cancer	9.86e-06	0.000231	CcSEcCtD
Cabazitaxel—Tinnitus—Doxorubicin—prostate cancer	9.84e-06	0.00023	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Docetaxel—prostate cancer	9.82e-06	0.00023	CcSEcCtD
Cabazitaxel—Flushing—Doxorubicin—prostate cancer	9.79e-06	0.000229	CcSEcCtD
Cabazitaxel—Cardiac disorder—Doxorubicin—prostate cancer	9.79e-06	0.000229	CcSEcCtD
Cabazitaxel—Dysgeusia—Epirubicin—prostate cancer	9.72e-06	0.000227	CcSEcCtD
Cabazitaxel—Back pain—Epirubicin—prostate cancer	9.6e-06	0.000225	CcSEcCtD
Cabazitaxel—Feeling abnormal—Capecitabine—prostate cancer	9.58e-06	0.000224	CcSEcCtD
Cabazitaxel—Angiopathy—Doxorubicin—prostate cancer	9.57e-06	0.000224	CcSEcCtD
Cabazitaxel—Dizziness—Etoposide—prostate cancer	9.56e-06	0.000224	CcSEcCtD
Cabazitaxel—Muscle spasms—Epirubicin—prostate cancer	9.54e-06	0.000223	CcSEcCtD
Cabazitaxel—Immune system disorder—Doxorubicin—prostate cancer	9.53e-06	0.000223	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Capecitabine—prostate cancer	9.51e-06	0.000222	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Doxorubicin—prostate cancer	9.51e-06	0.000222	CcSEcCtD
Cabazitaxel—Abdominal pain—Docetaxel—prostate cancer	9.49e-06	0.000222	CcSEcCtD
Cabazitaxel—Body temperature increased—Docetaxel—prostate cancer	9.49e-06	0.000222	CcSEcCtD
Cabazitaxel—Chills—Doxorubicin—prostate cancer	9.47e-06	0.000221	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Prednisone—prostate cancer	9.44e-06	0.000221	CcSEcCtD
Cabazitaxel—Arrhythmia—Doxorubicin—prostate cancer	9.43e-06	0.000221	CcSEcCtD
Cabazitaxel—Alopecia—Doxorubicin—prostate cancer	9.32e-06	0.000218	CcSEcCtD
Cabazitaxel—Paraesthesia—Prednisone—prostate cancer	9.3e-06	0.000218	CcSEcCtD
Cabazitaxel—Mental disorder—Doxorubicin—prostate cancer	9.24e-06	0.000216	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Epirubicin—prostate cancer	9.21e-06	0.000215	CcSEcCtD
Cabazitaxel—Abdominal pain—Capecitabine—prostate cancer	9.19e-06	0.000215	CcSEcCtD
Cabazitaxel—Body temperature increased—Capecitabine—prostate cancer	9.19e-06	0.000215	CcSEcCtD
Cabazitaxel—Vomiting—Etoposide—prostate cancer	9.19e-06	0.000215	CcSEcCtD
Cabazitaxel—Erythema—Doxorubicin—prostate cancer	9.18e-06	0.000215	CcSEcCtD
Cabazitaxel—Malnutrition—Doxorubicin—prostate cancer	9.18e-06	0.000215	CcSEcCtD
Cabazitaxel—Anaemia—Epirubicin—prostate cancer	9.17e-06	0.000215	CcSEcCtD
Cabazitaxel—Dyspepsia—Prednisone—prostate cancer	9.12e-06	0.000213	CcSEcCtD
Cabazitaxel—Headache—Etoposide—prostate cancer	9.05e-06	0.000212	CcSEcCtD
Cabazitaxel—Decreased appetite—Prednisone—prostate cancer	9e-06	0.000211	CcSEcCtD
Cabazitaxel—Dysgeusia—Doxorubicin—prostate cancer	8.99e-06	0.00021	CcSEcCtD
Cabazitaxel—Malaise—Epirubicin—prostate cancer	8.95e-06	0.000209	CcSEcCtD
Cabazitaxel—Fatigue—Prednisone—prostate cancer	8.93e-06	0.000209	CcSEcCtD
Cabazitaxel—Vertigo—Epirubicin—prostate cancer	8.92e-06	0.000209	CcSEcCtD
Cabazitaxel—Leukopenia—Epirubicin—prostate cancer	8.88e-06	0.000208	CcSEcCtD
Cabazitaxel—Back pain—Doxorubicin—prostate cancer	8.88e-06	0.000208	CcSEcCtD
Cabazitaxel—Constipation—Prednisone—prostate cancer	8.86e-06	0.000207	CcSEcCtD
Cabazitaxel—Hypersensitivity—Docetaxel—prostate cancer	8.85e-06	0.000207	CcSEcCtD
Cabazitaxel—Muscle spasms—Doxorubicin—prostate cancer	8.83e-06	0.000207	CcSEcCtD
Cabazitaxel—Cough—Epirubicin—prostate cancer	8.66e-06	0.000203	CcSEcCtD
Cabazitaxel—Asthenia—Docetaxel—prostate cancer	8.62e-06	0.000202	CcSEcCtD
Cabazitaxel—Nausea—Etoposide—prostate cancer	8.58e-06	0.000201	CcSEcCtD
Cabazitaxel—Hypertension—Epirubicin—prostate cancer	8.57e-06	0.000201	CcSEcCtD
Cabazitaxel—Hypersensitivity—Capecitabine—prostate cancer	8.57e-06	0.0002	CcSEcCtD
Cabazitaxel—Feeling abnormal—Prednisone—prostate cancer	8.54e-06	0.0002	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Doxorubicin—prostate cancer	8.52e-06	0.000199	CcSEcCtD
Cabazitaxel—Anaemia—Doxorubicin—prostate cancer	8.49e-06	0.000199	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Prednisone—prostate cancer	8.47e-06	0.000198	CcSEcCtD
Cabazitaxel—Arthralgia—Epirubicin—prostate cancer	8.45e-06	0.000198	CcSEcCtD
Cabazitaxel—Myalgia—Epirubicin—prostate cancer	8.45e-06	0.000198	CcSEcCtD
Cabazitaxel—Chest pain—Epirubicin—prostate cancer	8.45e-06	0.000198	CcSEcCtD
Cabazitaxel—Anxiety—Epirubicin—prostate cancer	8.42e-06	0.000197	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	8.39e-06	0.000196	CcSEcCtD
Cabazitaxel—Discomfort—Epirubicin—prostate cancer	8.35e-06	0.000195	CcSEcCtD
Cabazitaxel—Asthenia—Capecitabine—prostate cancer	8.34e-06	0.000195	CcSEcCtD
Cabazitaxel—Malaise—Doxorubicin—prostate cancer	8.28e-06	0.000194	CcSEcCtD
Cabazitaxel—Dry mouth—Epirubicin—prostate cancer	8.26e-06	0.000193	CcSEcCtD
Cabazitaxel—Vertigo—Doxorubicin—prostate cancer	8.25e-06	0.000193	CcSEcCtD
Cabazitaxel—Leukopenia—Doxorubicin—prostate cancer	8.22e-06	0.000192	CcSEcCtD
Cabazitaxel—Diarrhoea—Docetaxel—prostate cancer	8.22e-06	0.000192	CcSEcCtD
Cabazitaxel—Abdominal pain—Prednisone—prostate cancer	8.19e-06	0.000192	CcSEcCtD
Cabazitaxel—Body temperature increased—Prednisone—prostate cancer	8.19e-06	0.000192	CcSEcCtD
Cabazitaxel—Confusional state—Epirubicin—prostate cancer	8.17e-06	0.000191	CcSEcCtD
Cabazitaxel—Oedema—Epirubicin—prostate cancer	8.1e-06	0.00019	CcSEcCtD
Cabazitaxel—Infection—Epirubicin—prostate cancer	8.05e-06	0.000188	CcSEcCtD
Cabazitaxel—Cough—Doxorubicin—prostate cancer	8.01e-06	0.000188	CcSEcCtD
Cabazitaxel—Diarrhoea—Capecitabine—prostate cancer	7.96e-06	0.000186	CcSEcCtD
Cabazitaxel—Nervous system disorder—Epirubicin—prostate cancer	7.94e-06	0.000186	CcSEcCtD
Cabazitaxel—Dizziness—Docetaxel—prostate cancer	7.94e-06	0.000186	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Epirubicin—prostate cancer	7.93e-06	0.000186	CcSEcCtD
Cabazitaxel—Hypertension—Doxorubicin—prostate cancer	7.93e-06	0.000186	CcSEcCtD
Cabazitaxel—Tachycardia—Epirubicin—prostate cancer	7.91e-06	0.000185	CcSEcCtD
Cabazitaxel—Skin disorder—Epirubicin—prostate cancer	7.87e-06	0.000184	CcSEcCtD
Cabazitaxel—Arthralgia—Doxorubicin—prostate cancer	7.82e-06	0.000183	CcSEcCtD
Cabazitaxel—Chest pain—Doxorubicin—prostate cancer	7.82e-06	0.000183	CcSEcCtD
Cabazitaxel—Myalgia—Doxorubicin—prostate cancer	7.82e-06	0.000183	CcSEcCtD
Cabazitaxel—Anxiety—Doxorubicin—prostate cancer	7.79e-06	0.000182	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	7.77e-06	0.000182	CcSEcCtD
Cabazitaxel—Discomfort—Doxorubicin—prostate cancer	7.73e-06	0.000181	CcSEcCtD
Cabazitaxel—Anorexia—Epirubicin—prostate cancer	7.72e-06	0.000181	CcSEcCtD
Cabazitaxel—Dizziness—Capecitabine—prostate cancer	7.69e-06	0.00018	CcSEcCtD
Cabazitaxel—Dry mouth—Doxorubicin—prostate cancer	7.65e-06	0.000179	CcSEcCtD
Cabazitaxel—Vomiting—Docetaxel—prostate cancer	7.64e-06	0.000179	CcSEcCtD
Cabazitaxel—Hypersensitivity—Prednisone—prostate cancer	7.63e-06	0.000179	CcSEcCtD
Cabazitaxel—Hypotension—Epirubicin—prostate cancer	7.57e-06	0.000177	CcSEcCtD
Cabazitaxel—Confusional state—Doxorubicin—prostate cancer	7.56e-06	0.000177	CcSEcCtD
Cabazitaxel—Headache—Docetaxel—prostate cancer	7.52e-06	0.000176	CcSEcCtD
Cabazitaxel—Oedema—Doxorubicin—prostate cancer	7.5e-06	0.000175	CcSEcCtD
Cabazitaxel—Infection—Doxorubicin—prostate cancer	7.45e-06	0.000174	CcSEcCtD
Cabazitaxel—Asthenia—Prednisone—prostate cancer	7.43e-06	0.000174	CcSEcCtD
Cabazitaxel—Vomiting—Capecitabine—prostate cancer	7.39e-06	0.000173	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Epirubicin—prostate cancer	7.38e-06	0.000173	CcSEcCtD
Cabazitaxel—Nervous system disorder—Doxorubicin—prostate cancer	7.35e-06	0.000172	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Doxorubicin—prostate cancer	7.34e-06	0.000172	CcSEcCtD
Cabazitaxel—Tachycardia—Doxorubicin—prostate cancer	7.32e-06	0.000171	CcSEcCtD
Cabazitaxel—Headache—Capecitabine—prostate cancer	7.28e-06	0.00017	CcSEcCtD
Cabazitaxel—Skin disorder—Doxorubicin—prostate cancer	7.28e-06	0.00017	CcSEcCtD
Cabazitaxel—Paraesthesia—Epirubicin—prostate cancer	7.27e-06	0.00017	CcSEcCtD
Cabazitaxel—Dyspnoea—Epirubicin—prostate cancer	7.22e-06	0.000169	CcSEcCtD
Cabazitaxel—Anorexia—Doxorubicin—prostate cancer	7.14e-06	0.000167	CcSEcCtD
Cabazitaxel—Nausea—Docetaxel—prostate cancer	7.13e-06	0.000167	CcSEcCtD
Cabazitaxel—Dyspepsia—Epirubicin—prostate cancer	7.13e-06	0.000167	CcSEcCtD
Cabazitaxel—Diarrhoea—Prednisone—prostate cancer	7.09e-06	0.000166	CcSEcCtD
Cabazitaxel—Decreased appetite—Epirubicin—prostate cancer	7.04e-06	0.000165	CcSEcCtD
Cabazitaxel—Hypotension—Doxorubicin—prostate cancer	7e-06	0.000164	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Epirubicin—prostate cancer	6.99e-06	0.000164	CcSEcCtD
Cabazitaxel—Fatigue—Epirubicin—prostate cancer	6.98e-06	0.000163	CcSEcCtD
Cabazitaxel—Pain—Epirubicin—prostate cancer	6.93e-06	0.000162	CcSEcCtD
Cabazitaxel—Constipation—Epirubicin—prostate cancer	6.93e-06	0.000162	CcSEcCtD
Cabazitaxel—Nausea—Capecitabine—prostate cancer	6.91e-06	0.000162	CcSEcCtD
Cabazitaxel—Dizziness—Prednisone—prostate cancer	6.85e-06	0.00016	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Doxorubicin—prostate cancer	6.83e-06	0.00016	CcSEcCtD
Cabazitaxel—Paraesthesia—Doxorubicin—prostate cancer	6.73e-06	0.000157	CcSEcCtD
Cabazitaxel—Dyspnoea—Doxorubicin—prostate cancer	6.68e-06	0.000156	CcSEcCtD
Cabazitaxel—Feeling abnormal—Epirubicin—prostate cancer	6.68e-06	0.000156	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Epirubicin—prostate cancer	6.62e-06	0.000155	CcSEcCtD
Cabazitaxel—Dyspepsia—Doxorubicin—prostate cancer	6.6e-06	0.000154	CcSEcCtD
Cabazitaxel—Vomiting—Prednisone—prostate cancer	6.59e-06	0.000154	CcSEcCtD
Cabazitaxel—Decreased appetite—Doxorubicin—prostate cancer	6.52e-06	0.000152	CcSEcCtD
Cabazitaxel—Headache—Prednisone—prostate cancer	6.49e-06	0.000152	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Doxorubicin—prostate cancer	6.47e-06	0.000151	CcSEcCtD
Cabazitaxel—Fatigue—Doxorubicin—prostate cancer	6.46e-06	0.000151	CcSEcCtD
Cabazitaxel—Constipation—Doxorubicin—prostate cancer	6.41e-06	0.00015	CcSEcCtD
Cabazitaxel—Pain—Doxorubicin—prostate cancer	6.41e-06	0.00015	CcSEcCtD
Cabazitaxel—Abdominal pain—Epirubicin—prostate cancer	6.4e-06	0.00015	CcSEcCtD
Cabazitaxel—Body temperature increased—Epirubicin—prostate cancer	6.4e-06	0.00015	CcSEcCtD
Cabazitaxel—Feeling abnormal—Doxorubicin—prostate cancer	6.18e-06	0.000145	CcSEcCtD
Cabazitaxel—Nausea—Prednisone—prostate cancer	6.15e-06	0.000144	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Doxorubicin—prostate cancer	6.13e-06	0.000143	CcSEcCtD
Cabazitaxel—Hypersensitivity—Epirubicin—prostate cancer	5.97e-06	0.00014	CcSEcCtD
Cabazitaxel—Body temperature increased—Doxorubicin—prostate cancer	5.93e-06	0.000139	CcSEcCtD
Cabazitaxel—Abdominal pain—Doxorubicin—prostate cancer	5.93e-06	0.000139	CcSEcCtD
Cabazitaxel—Asthenia—Epirubicin—prostate cancer	5.81e-06	0.000136	CcSEcCtD
Cabazitaxel—Diarrhoea—Epirubicin—prostate cancer	5.54e-06	0.00013	CcSEcCtD
Cabazitaxel—Hypersensitivity—Doxorubicin—prostate cancer	5.52e-06	0.000129	CcSEcCtD
Cabazitaxel—Asthenia—Doxorubicin—prostate cancer	5.38e-06	0.000126	CcSEcCtD
Cabazitaxel—Dizziness—Epirubicin—prostate cancer	5.36e-06	0.000125	CcSEcCtD
Cabazitaxel—Vomiting—Epirubicin—prostate cancer	5.15e-06	0.000121	CcSEcCtD
Cabazitaxel—Diarrhoea—Doxorubicin—prostate cancer	5.13e-06	0.00012	CcSEcCtD
Cabazitaxel—Headache—Epirubicin—prostate cancer	5.07e-06	0.000119	CcSEcCtD
Cabazitaxel—Dizziness—Doxorubicin—prostate cancer	4.96e-06	0.000116	CcSEcCtD
Cabazitaxel—Nausea—Epirubicin—prostate cancer	4.81e-06	0.000113	CcSEcCtD
Cabazitaxel—Vomiting—Doxorubicin—prostate cancer	4.77e-06	0.000112	CcSEcCtD
Cabazitaxel—Headache—Doxorubicin—prostate cancer	4.7e-06	0.00011	CcSEcCtD
Cabazitaxel—Nausea—Doxorubicin—prostate cancer	4.45e-06	0.000104	CcSEcCtD
Cabazitaxel—SLCO1B1—Metabolism—ERCC2—prostate cancer	8.31e-07	2.84e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NCOA2—prostate cancer	8.3e-07	2.83e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—TYMS—prostate cancer	8.28e-07	2.83e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	8.25e-07	2.82e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—HPGDS—prostate cancer	8.22e-07	2.81e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SLC22A1—prostate cancer	8.19e-07	2.8e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	8.19e-07	2.8e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTM1—prostate cancer	8.18e-07	2.79e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP2C19—prostate cancer	8.17e-07	2.79e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—NOS3—prostate cancer	8.11e-07	2.77e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—TNFRSF21—prostate cancer	8.05e-07	2.75e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—LPL—prostate cancer	8.03e-07	2.74e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SULT2A1—prostate cancer	7.98e-07	2.73e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	7.98e-07	2.73e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ACHE—prostate cancer	7.97e-07	2.72e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTT1—prostate cancer	7.97e-07	2.72e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—SLC5A5—prostate cancer	7.92e-07	2.7e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP2A6—prostate cancer	7.88e-07	2.69e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—MED12—prostate cancer	7.85e-07	2.68e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	7.85e-07	2.68e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP7B1—prostate cancer	7.83e-07	2.67e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—MTAP—prostate cancer	7.83e-07	2.67e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—MTHFR—prostate cancer	7.81e-07	2.67e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GNG5—prostate cancer	7.79e-07	2.66e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYP1A1—prostate cancer	7.76e-07	2.65e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP2E1—prostate cancer	7.74e-07	2.64e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ERCC2—prostate cancer	7.69e-07	2.63e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—AKR1C3—prostate cancer	7.67e-07	2.62e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PPARA—prostate cancer	7.66e-07	2.62e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NQO1—prostate cancer	7.65e-07	2.61e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SULT1E1—prostate cancer	7.63e-07	2.61e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SRD5A1—prostate cancer	7.63e-07	2.61e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PRKACB—prostate cancer	7.63e-07	2.6e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP17A1—prostate cancer	7.55e-07	2.58e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—TH—prostate cancer	7.54e-07	2.57e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NCOA3—prostate cancer	7.51e-07	2.56e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CB—prostate cancer	7.48e-07	2.56e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP3A4—prostate cancer	7.46e-07	2.55e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	7.44e-07	2.54e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTGS2—prostate cancer	7.42e-07	2.53e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP1B1—prostate cancer	7.33e-07	2.5e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ACSL4—prostate cancer	7.28e-07	2.49e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HSD17B3—prostate cancer	7.28e-07	2.49e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—MTHFR—prostate cancer	7.23e-07	2.47e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CAV1—prostate cancer	7.2e-07	2.46e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NCOA2—prostate cancer	7.19e-07	2.46e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—HPGDS—prostate cancer	7.16e-07	2.45e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP2C19—prostate cancer	7.12e-07	2.43e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GGT1—prostate cancer	7.1e-07	2.43e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PPARA—prostate cancer	7.09e-07	2.42e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NCOA1—prostate cancer	7e-07	2.39e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ARG2—prostate cancer	6.98e-07	2.38e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PHGDH—prostate cancer	6.98e-07	2.38e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—UMPS—prostate cancer	6.98e-07	2.38e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTT1—prostate cancer	6.95e-07	2.37e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ACHE—prostate cancer	6.95e-07	2.37e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP19A1—prostate cancer	6.9e-07	2.35e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.88e-07	2.35e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP2A6—prostate cancer	6.87e-07	2.34e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—SLC5A5—prostate cancer	6.86e-07	2.34e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—LDHB—prostate cancer	6.85e-07	2.34e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	6.74e-07	2.3e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP3A5—prostate cancer	6.72e-07	2.29e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP2E1—prostate cancer	6.7e-07	2.29e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—AKR1C3—prostate cancer	6.68e-07	2.28e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CAV1—prostate cancer	6.67e-07	2.28e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—RXRA—prostate cancer	6.65e-07	2.27e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PRKACB—prostate cancer	6.64e-07	2.27e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NQO1—prostate cancer	6.63e-07	2.26e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP17A1—prostate cancer	6.57e-07	2.24e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CG—prostate cancer	6.56e-07	2.24e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—TH—prostate cancer	6.53e-07	2.23e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.5e-07	2.22e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PDHA1—prostate cancer	6.49e-07	2.22e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—TCN2—prostate cancer	6.49e-07	2.22e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—UCP3—prostate cancer	6.49e-07	2.22e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTA3—prostate cancer	6.49e-07	2.22e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.49e-07	2.22e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTEN—prostate cancer	6.47e-07	2.21e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP3A4—prostate cancer	6.46e-07	2.21e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	6.43e-07	2.19e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—COMT—prostate cancer	6.41e-07	2.19e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTP1—prostate cancer	6.38e-07	2.18e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP1B1—prostate cancer	6.35e-07	2.17e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ITPR1—prostate cancer	6.28e-07	2.14e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NCOA2—prostate cancer	6.26e-07	2.14e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—INS—prostate cancer	6.21e-07	2.12e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SLC22A3—prostate cancer	6.19e-07	2.11e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HSD3B1—prostate cancer	6.19e-07	2.11e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—EP300—prostate cancer	6.17e-07	2.11e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GGT1—prostate cancer	6.15e-07	2.1e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CREBBP—prostate cancer	6.08e-07	2.08e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CG—prostate cancer	6.08e-07	2.07e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NCOA1—prostate cancer	6.06e-07	2.07e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SLC5A5—prostate cancer	5.98e-07	2.04e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP19A1—prostate cancer	5.97e-07	2.04e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTA4—prostate cancer	5.94e-07	2.03e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—TBXAS1—prostate cancer	5.94e-07	2.03e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—TYMS—prostate cancer	5.93e-07	2.03e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTM1—prostate cancer	5.86e-07	2e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP2E1—prostate cancer	5.84e-07	1.99e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTA2—prostate cancer	5.78e-07	1.98e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NQO1—prostate cancer	5.77e-07	1.97e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CD—prostate cancer	5.77e-07	1.97e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—RXRA—prostate cancer	5.76e-07	1.97e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—LPL—prostate cancer	5.75e-07	1.96e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—INS—prostate cancer	5.75e-07	1.96e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ABCG5—prostate cancer	5.71e-07	1.95e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.71e-07	1.95e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—TH—prostate cancer	5.69e-07	1.94e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CREBBP—prostate cancer	5.63e-07	1.92e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP3A4—prostate cancer	5.63e-07	1.92e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.61e-07	1.91e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTA1—prostate cancer	5.58e-07	1.91e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP1A1—prostate cancer	5.56e-07	1.9e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—COMT—prostate cancer	5.55e-07	1.9e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP1B1—prostate cancer	5.53e-07	1.89e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTP1—prostate cancer	5.53e-07	1.89e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HSD3B2—prostate cancer	5.52e-07	1.88e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTO1—prostate cancer	5.52e-07	1.88e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NAT2—prostate cancer	5.52e-07	1.88e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ERCC2—prostate cancer	5.51e-07	1.88e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—NOS3—prostate cancer	5.45e-07	1.86e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ITPR1—prostate cancer	5.44e-07	1.86e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GGT1—prostate cancer	5.36e-07	1.83e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.35e-07	1.83e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CD—prostate cancer	5.34e-07	1.82e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PLCB2—prostate cancer	5.29e-07	1.81e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP2C18—prostate cancer	5.29e-07	1.81e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—LRP2—prostate cancer	5.29e-07	1.81e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NCOA1—prostate cancer	5.28e-07	1.8e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP19A1—prostate cancer	5.2e-07	1.78e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—P4HB—prostate cancer	5.19e-07	1.77e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—MTHFR—prostate cancer	5.18e-07	1.77e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—TYMS—prostate cancer	5.14e-07	1.75e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PPARA—prostate cancer	5.08e-07	1.74e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTM1—prostate cancer	5.08e-07	1.73e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SLC22A1—prostate cancer	5.05e-07	1.72e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NOS3—prostate cancer	5.04e-07	1.72e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CB—prostate cancer	5.03e-07	1.72e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—RXRA—prostate cancer	5.02e-07	1.71e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—LPL—prostate cancer	4.98e-07	1.7e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTGS2—prostate cancer	4.98e-07	1.7e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.92e-07	1.68e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—MED12—prostate cancer	4.84e-07	1.65e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—COMT—prostate cancer	4.84e-07	1.65e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTP1—prostate cancer	4.81e-07	1.64e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP1A1—prostate cancer	4.81e-07	1.64e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GNG5—prostate cancer	4.8e-07	1.64e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CAV1—prostate cancer	4.78e-07	1.63e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ERCC2—prostate cancer	4.77e-07	1.63e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ITPR1—prostate cancer	4.74e-07	1.62e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CB—prostate cancer	4.66e-07	1.59e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NCOA3—prostate cancer	4.62e-07	1.58e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTGS2—prostate cancer	4.61e-07	1.58e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CA—prostate cancer	4.56e-07	1.56e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—MTHFR—prostate cancer	4.49e-07	1.53e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—TYMS—prostate cancer	4.48e-07	1.53e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTM1—prostate cancer	4.42e-07	1.51e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HPGDS—prostate cancer	4.41e-07	1.51e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PPARA—prostate cancer	4.4e-07	1.5e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.38e-07	1.5e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CG—prostate cancer	4.35e-07	1.49e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTEN—prostate cancer	4.34e-07	1.48e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—LPL—prostate cancer	4.34e-07	1.48e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ACHE—prostate cancer	4.28e-07	1.46e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTT1—prostate cancer	4.28e-07	1.46e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.23e-07	1.44e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP1A1—prostate cancer	4.19e-07	1.43e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ERCC2—prostate cancer	4.16e-07	1.42e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—EP300—prostate cancer	4.14e-07	1.41e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CAV1—prostate cancer	4.14e-07	1.41e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—INS—prostate cancer	4.12e-07	1.41e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.11e-07	1.4e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PRKACB—prostate cancer	4.09e-07	1.4e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.05e-07	1.38e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CREBBP—prostate cancer	4.04e-07	1.38e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTEN—prostate cancer	4.02e-07	1.37e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.95e-07	1.35e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—MTHFR—prostate cancer	3.91e-07	1.34e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NCOA2—prostate cancer	3.86e-07	1.32e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—EP300—prostate cancer	3.84e-07	1.31e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PPARA—prostate cancer	3.84e-07	1.31e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CD—prostate cancer	3.83e-07	1.31e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CG—prostate cancer	3.77e-07	1.29e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—AKT1—prostate cancer	3.73e-07	1.27e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.68e-07	1.26e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NOS3—prostate cancer	3.61e-07	1.23e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CAV1—prostate cancer	3.61e-07	1.23e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.6e-07	1.23e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—INS—prostate cancer	3.57e-07	1.22e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NQO1—prostate cancer	3.56e-07	1.21e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—TH—prostate cancer	3.5e-07	1.2e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CREBBP—prostate cancer	3.5e-07	1.19e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.41e-07	1.16e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CB—prostate cancer	3.34e-07	1.14e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CD—prostate cancer	3.31e-07	1.13e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTGS2—prostate cancer	3.31e-07	1.13e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GGT1—prostate cancer	3.3e-07	1.13e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CG—prostate cancer	3.28e-07	1.12e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NCOA1—prostate cancer	3.25e-07	1.11e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.21e-07	1.09e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NOS3—prostate cancer	3.13e-07	1.07e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—INS—prostate cancer	3.11e-07	1.06e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—RXRA—prostate cancer	3.09e-07	1.06e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CA—prostate cancer	3.07e-07	1.05e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CREBBP—prostate cancer	3.05e-07	1.04e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—COMT—prostate cancer	2.98e-07	1.02e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTP1—prostate cancer	2.97e-07	1.01e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ITPR1—prostate cancer	2.92e-07	9.97e-06	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CB—prostate cancer	2.89e-07	9.87e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CD—prostate cancer	2.89e-07	9.86e-06	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTEN—prostate cancer	2.88e-07	9.84e-06	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTGS2—prostate cancer	2.86e-07	9.78e-06	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CA—prostate cancer	2.84e-07	9.69e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—TYMS—prostate cancer	2.76e-07	9.42e-06	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—EP300—prostate cancer	2.75e-07	9.39e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NOS3—prostate cancer	2.73e-07	9.31e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTM1—prostate cancer	2.73e-07	9.31e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—LPL—prostate cancer	2.68e-07	9.14e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.58e-07	8.82e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ERCC2—prostate cancer	2.56e-07	8.75e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CB—prostate cancer	2.52e-07	8.59e-06	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—AKT1—prostate cancer	2.5e-07	8.55e-06	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTEN—prostate cancer	2.5e-07	8.52e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTGS2—prostate cancer	2.49e-07	8.52e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—MTHFR—prostate cancer	2.41e-07	8.23e-06	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—EP300—prostate cancer	2.38e-07	8.13e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PPARA—prostate cancer	2.36e-07	8.07e-06	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—AKT1—prostate cancer	2.32e-07	7.92e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CAV1—prostate cancer	2.22e-07	7.59e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTEN—prostate cancer	2.18e-07	7.43e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—EP300—prostate cancer	2.07e-07	7.08e-06	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CA—prostate cancer	2.03e-07	6.94e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.02e-07	6.91e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—INS—prostate cancer	1.92e-07	6.54e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CREBBP—prostate cancer	1.88e-07	6.41e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.78e-07	6.08e-06	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CA—prostate cancer	1.76e-07	6.01e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NOS3—prostate cancer	1.68e-07	5.74e-06	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—AKT1—prostate cancer	1.66e-07	5.67e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.55e-07	5.3e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTGS2—prostate cancer	1.54e-07	5.25e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CA—prostate cancer	1.53e-07	5.24e-06	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—AKT1—prostate cancer	1.44e-07	4.91e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTEN—prostate cancer	1.34e-07	4.58e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—EP300—prostate cancer	1.28e-07	4.36e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—AKT1—prostate cancer	1.25e-07	4.28e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CA—prostate cancer	9.45e-08	3.23e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—AKT1—prostate cancer	7.72e-08	2.64e-06	CbGpPWpGaD
